Keymed Biosciences (2162.HK) Q1 2024 Earnings

Mar 26Confirmed
Q2 2023
Q1 2024
-1.71
-1.37
-1.04
-0.71

Details

Expected EPS
N/A
Actual EPS
-1.70791963425
Surprise EPS
N/A
Surprise Percent
N/A

Description

⁨Keymed Biosciences⁩ (⁦2162.HK⁩) has reported earnings of ⁦-1.70791963425⁩ per share for ⁦Q1 2024⁩.

0 Comments

Share your thoughts